Eisai Co., Ltd. announced today that amyotrophic lateral sclerosis (ALS) treatment “Rozebalamin® for Injection 25 mg” ...

Rozebalamin, an ultra-high dose vitamin B12 treatment, was approved in Japan to slow disease progression in people with ALS.

This comes after drug manufacturers issued applications to increase prices due to increased cost of ingredients, production, ...

The National Pharmaceutical Pricing Authority (NPPA) on Wednesday fixed the retail price of 20 new drugs under the provisions of the Drugs Prices Control Order (DPCO), 2013. These drugs are used for ...

In another Gazzette notification, the drug pricing regulator fixed the retail price of 20 new drugs under the provisions of ...

Retail price for cefuroxime axetil tablet from Dr Reddy's Laboratories, L-carnitine mecobalamin and folic acid tablet from Cadila Pharmaceuticals, sitagliptin, metformin hydrochloride and glimepiride ...

Others include Amgen's Tepezza (tezepelumab) for thyroid eye disease, Takeda's Fruzaqla (fruquintinib) for advanced colorectal cancer, Eisai's Rozebalamin (mecobalamin) for amyotrophic lateral ...

The retail price of cefuroxime axetil tablet from Dr Reddy's Laboratories, L- Carnitinr mecobalamin and folic acid tablet from cadila Pharmaceuticals was also fixed. "After detailed deliberations ...

Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA) , Ministry of Chemicals and Fertilizers, ...